China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Single-Center, Prospective, Non-Interventional Observational Study of Bevacizumab-Containing Regimens Combined with Hyperthermia for Multiple Cancer Types'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131857

Registration Time: 2026/09/07

Type: Observational study

Primary Sponsor: People's Hospital of Zhengzhou

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341955

Published by HT Digital Content Services with permission from Health Daily Digest....